|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500107625 |
|
最近更新日期: Date of Last Refreshed on: |
2025-08-15 09:49:23 |
|
注册时间: Date of Registration: |
2025-08-15 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
遗忘膝关节评分早期变化趋势的影响因素分析 |
|
Public title: |
Analysis of Influencing Factors on the Early Change Trend of the Forgotten Joint Score |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
遗忘膝关节评分早期变化趋势的影响因素分析 |
|
Scientific title: |
Analysis of Influencing Factors on the Early Change Trend of the Forgotten Joint Score |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈权 |
研究负责人: |
张晓岗 |
|
Applicant: |
Quan Chen |
Study leader: |
Xiaogang Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 135 9887 1259 |
研究负责人电话: Study leader's telephone: |
+86 135 9887 1259 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1196298816@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1196298816@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
新疆维吾尔自治区新疆医科大学新医路393号 |
研究负责人通讯地址: |
新疆维吾尔自治区新疆医科大学新医路393号 |
|
Applicant address: |
393 Xinyi Road, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Xinjiang |
Study leader's address: |
3393 Xinyi Road, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Xinjiang |
|
申请注册联系人邮政编码: Applicant postcode: |
830000 |
研究负责人邮政编码: Study leader's postcode: |
830000 |
|
申请人所在单位: |
新疆医科大学第一附属医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Xinjiang Medical University |
||
|
研究负责人所在单位: |
新疆医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Xinjiang Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
K202407-13 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
新疆医科大学第一附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-07-23 00:00:00 |
||
|
伦理委员会联系人: |
郑小洁 |
||
|
Contact Name of the ethic committee: |
Xiaojie Zheng |
||
|
伦理委员会联系地址: |
新疆维吾尔自治区新疆医科大学新医路393号 |
||
|
Contact Address of the ethic committee: |
393 Xinyi Road, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Xinjiang |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 181 4082 6570 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
新疆医科大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Xinjiang Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
新疆维吾尔自治区新疆医科大学新医路393号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
393 Xinyi Road, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Xinjiang |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self support |
||||||||||||||||||||||
|
Target disease: |
Knee Osteoarthritis |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
探讨初次全膝关节置换术后1年内遗忘关节评分的动态演变轨迹及其影响因素 |
||||||||||||||||||||||
|
Objectives of Study: |
Exploring the dynamic evolution of the Forgotten Joint Score and its influencing factors within one year following primary total knee arthroplasty |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.2023年5月1日后于我院行初次TKA的患者; 2.住院期间留存电话中有1个以上电话能接通的患者。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients who underwent primary TKA in our hospital after May 1, 2023; 2. Patients with at least one accessible phone number among those retained during hospitalization. |
||||||||||||||||||||||
|
排除标准: |
1.既往行TKA手术患者; 2.不能接受长期电话随访患者; 3.年龄超过85岁患者; 4.随访时间未满1年或随访过程中死亡的患者; 5.电话持续无法接通或持续关机患者; 6.术后出现感染的患者; 7. 2个月以内行对侧TKA手术患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with a history of TKA surgery; 2. Patients unable to accept long-term telephone follow-up; 3. Patients over 85 years of age; 4. Patients with a follow-up duration of less than 1 year or who died during follow-up; 5. Patients whose phone calls were persistently unreachable or whose phones were persistently powered off; 6. Patients with postoperative infection; 7. Patients who underwent contralateral TKA surgery within 2 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-08-01 00:00:00至 To 2026-09-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-08-02 00:00:00 至 To 2026-09-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究完成后共享数据,研究预计2027年完成,数据将于Vivli 平台进行公式 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Data will be shared on the Vivli platform after the study is completed. The study is expected to be finished in 2027. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
整个试验过程严格执行临床试验质量管理规范,所有纸质 CRF 记录完整、 真实、清晰、客观后将试验数据输入计算机,锁定数据后储存。病例报告表(CRF) 由研究者填写,每位入选病例必须完成病例报告表。完成的病例报告表由研究者 进行数据录入与管理工作。数据录入后,病例报告表的内容不再做修改。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The whole trial process strictly implemented the good clinical practice quality management, all paper CRF records were complete, true, clear and objective, the trial data were input into the computer, and the data were stored after locking. The case report form (CRF) was completed by the investigators and was mandatory for each enrolled patient. Data entry and management of completed case-report forms were performed by the investigators. No changes were made to the contents of the case report form after data entry. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |